Eight patients suffering from cutaneous leishmaniasis acquired in Belize were treated with 800 mg oral ketoconazole daily for 28 days . Four were infected with Leishmania mexicana mexicana and four with Leishmania braziliensis braziliensis. On complelion of therapy, all cases of Leishmania mexicalla mexicana infection and one of Leishmania braziliensis braziliensis infection showed significant clinical improvement. No side-effects were observed during this study which suggests that ketoconazole might be a safe and effective form of therapy for cutaneous leishmaniasis caused by Leishmania mexicona mexicana.
- © 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.